Annual Current Assets
$154.39 M
+$1.68 M+1.10%
30 September 2023
Summary:
Anavex Life Sciences annual total current assets is currently $154.39 million, with the most recent change of +$1.68 million (+1.10%) on 30 September 2023. During the last 3 years, it has fallen by -$7.23 million (-4.47%). AVXL annual current assets is now -4.47% below its all-time high of $161.62 million, reached on 30 September 2021.AVXL Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$141.53 M
-$2.98 M-2.06%
30 June 2024
Summary:
Anavex Life Sciences quarterly total current assets is currently $141.53 million, with the most recent change of -$2.98 million (-2.06%) on 30 June 2024. Over the past year, it has dropped by -$12.85 million (-8.32%). AVXL quarterly current assets is now -14.95% below its all-time high of $166.42 million, reached on 30 June 2021.AVXL Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVXL Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -8.3% |
| 3 y3 years | -4.5% | -12.4% |
| 5 y5 years | +509.5% | +458.8% |
AVXL Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.5% | +1.1% | -12.4% | at low |
| 5 y | 5 years | -4.5% | +509.5% | -14.9% | +458.8% |
| alltime | all time | -4.5% | -14.9% |
Anavex Life Sciences Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $141.53 M(-2.1%) |
| Mar 2024 | - | $144.52 M(-2.4%) |
| Dec 2023 | - | $148.07 M(-4.1%) |
| Sept 2023 | $0.00(0.0%) | $154.39 M(-2.2%) |
| June 2023 | - | $157.81 M(-0.9%) |
| Mar 2023 | - | $159.19 M(+7.3%) |
| Dec 2022 | - | $148.37 M(-2.8%) |
| Sept 2022 | $0.00(0.0%) | $152.71 M(-4.7%) |
| June 2022 | - | $160.22 M(-0.0%) |
| Mar 2022 | - | $160.28 M(+2.2%) |
| Dec 2021 | - | $156.90 M(-2.9%) |
| Sept 2021 | $0.00(0.0%) | $161.62 M(-2.9%) |
| June 2021 | - | $166.42 M(+99.1%) |
| Mar 2021 | - | $83.57 M(+53.8%) |
| Dec 2020 | - | $54.33 M(+57.3%) |
| Sept 2020 | $0.00(0.0%) | $34.54 M(+9.2%) |
| June 2020 | - | $31.63 M(+2.0%) |
| Mar 2020 | - | $31.02 M(-1.3%) |
| Dec 2019 | - | $31.42 M(+24.1%) |
| Sept 2019 | $0.00(-100.0%) | $25.33 M(+16.1%) |
| June 2019 | - | $21.82 M(+6.2%) |
| Mar 2019 | - | $20.55 M(-7.0%) |
| Dec 2018 | - | $22.10 M(-15.2%) |
| Sept 2018 | $153.50 K(+192.9%) | $26.05 M(-2.6%) |
| June 2018 | - | $26.74 M(+3.6%) |
| Mar 2018 | - | $25.81 M(-8.8%) |
| Dec 2017 | - | $28.29 M(+1.8%) |
| Sept 2017 | $52.40 K(0.0%) | $27.79 M(+11.8%) |
| June 2017 | - | $24.85 M(+5.5%) |
| Mar 2017 | - | $23.55 M(+10.5%) |
| Dec 2016 | - | $21.32 M(+125.7%) |
| Sept 2016 | $52.40 K(+3930.8%) | $9.45 M(-4.0%) |
| June 2016 | - | $9.84 M(-18.7%) |
| Mar 2016 | - | $12.11 M(-13.6%) |
| Dec 2015 | - | $14.02 M(-9.3%) |
| Sept 2015 | $1300.00 | $15.47 M(+93.9%) |
| June 2015 | - | $7.98 M(+25.4%) |
| Mar 2015 | - | $6.36 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | - | $7.05 M(-4.1%) |
| Sept 2014 | $2200.00(>+9900.0%) | $7.35 M(-10.3%) |
| June 2014 | - | $8.20 M(-11.1%) |
| Mar 2014 | - | $9.22 M(+6097.6%) |
| Dec 2013 | - | $148.80 K(-62.2%) |
| Sept 2013 | $0.00(-100.0%) | $393.40 K(>+9900.0%) |
| June 2013 | - | $3500.00(+600.0%) |
| Mar 2013 | - | $500.00(-99.4%) |
| Dec 2012 | - | $79.80 K(+533.3%) |
| Sept 2012 | $600.00(-75.0%) | $12.60 K(-40.3%) |
| June 2012 | - | $21.10 K(-88.9%) |
| Mar 2012 | - | $189.60 K(+129.5%) |
| Dec 2011 | - | $82.60 K(-58.8%) |
| Sept 2011 | $2400.00(-41.5%) | $200.60 K(-84.3%) |
| June 2011 | - | $1.28 M(+1972.1%) |
| Mar 2011 | - | $61.60 K(-87.3%) |
| Dec 2010 | - | $485.70 K(+49.1%) |
| Sept 2010 | $4100.00(+141.2%) | $325.80 K(-78.8%) |
| June 2010 | - | $1.54 M(+574.9%) |
| Mar 2010 | - | $227.80 K(+219.9%) |
| Dec 2009 | - | $71.20 K(-82.5%) |
| Sept 2009 | $1700.00(+88.9%) | $407.00 K(-45.2%) |
| June 2009 | - | $742.60 K(+843.6%) |
| Mar 2009 | - | $78.70 K(>+9900.0%) |
| Dec 2008 | - | $600.00(-90.6%) |
| Sept 2008 | $900.00(>+9900.0%) | $6400.00(-40.7%) |
| June 2008 | - | $10.80 K(-23.9%) |
| Mar 2008 | - | $14.20 K(-75.8%) |
| Dec 2007 | - | $58.60 K(>+9900.0%) |
| Sept 2007 | $0.00(0.0%) | $0.00(-100.0%) |
| June 2007 | - | $100.00(-99.3%) |
| Mar 2007 | - | $15.00 K(+233.3%) |
| Dec 2006 | - | $4500.00(-64.0%) |
| Sept 2006 | $0.00(0.0%) | $12.50 K(-37.2%) |
| June 2006 | - | $19.90 K(>+9900.0%) |
| Mar 2006 | - | $100.00(0.0%) |
| Dec 2005 | - | $100.00(-90.0%) |
| Sept 2005 | $0.00(0.0%) | $1000.00 |
| Sept 2004 | $0.00 | - |
FAQ
- What is Anavex Life Sciences annual total current assets?
- What is the all time high annual current assets for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly total current assets?
- What is the all time high quarterly current assets for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly current assets year-on-year change?
What is Anavex Life Sciences annual total current assets?
The current annual current assets of AVXL is $154.39 M
What is the all time high annual current assets for Anavex Life Sciences?
Anavex Life Sciences all-time high annual total current assets is $161.62 M
What is Anavex Life Sciences quarterly total current assets?
The current quarterly current assets of AVXL is $141.53 M
What is the all time high quarterly current assets for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly total current assets is $166.42 M
What is Anavex Life Sciences quarterly current assets year-on-year change?
Over the past year, AVXL quarterly total current assets has changed by -$12.85 M (-8.32%)